Pharma · Private company
Bayer
Track this companyFree. Adds Bayer to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs26From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline26
- CarboplatinPhase 3 · Advanced Non-small Cell Lung Cancer, HER2 MutationClinicalTrials.gov · fetched Nov 12, 2026
- CisplatinPhase 3 · Advanced Non-small Cell Lung Cancer, HER2 MutationClinicalTrials.gov · fetched Nov 12, 2026
- Darolutamide (Nubeqa, BAY1841788)Phase 3 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- Finerenone (Kerendia, BAY94-8862)Phase 3 · Left Ventricular Systolic DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 3 · Advanced Non-small Cell Lung Cancer, HER2 MutationClinicalTrials.gov · fetched Nov 12, 2026
- PemetrexedPhase 3 · Advanced Non-small Cell Lung Cancer, HER2 MutationClinicalTrials.gov · fetched Nov 12, 2026
- SevabertinibPhase 3 · Advanced Non-small Cell Lung Cancer, HER2 MutationClinicalTrials.gov · fetched Nov 12, 2026
- BAY 3401016Phase 2 · Alport SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- BAY 3670549Phase 2 · Atrial FibrillationClinicalTrials.gov · fetched Nov 12, 2026
- BAY 3713372Phase 2 · MTAP-deleted Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- BAY2927088Phase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- BAY2927088_formulation APhase 2 · Advanced Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- BAY2927088_formulation B_1Phase 2 · Advanced Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- BAY2927088_formulation B_2Phase 2 · Advanced Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- BAY2927088_formulation B_3Phase 2 · Advanced Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- BAY 3547922Phase 1 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- BAY 3547926Phase 1 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- BAY 3713389Phase 1 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- BAY 3713391Phase 1 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- BAY3389934Phase 1 · SepsisClinicalTrials.gov · fetched Nov 12, 2026
- Damoctocog alfa pegol (Jivi, Bay94-9027)Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- Estrogen therapyEstrogen TherapyClinicalTrials.gov · fetched Nov 12, 2026
- Finerenone (BAY 94-8862)Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- larotrectinib(Vitrakvi, BAY2757556)Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionClinicalTrials.gov · fetched Nov 12, 2026
- Mirena levonorgestrel-releasing intrauterine systemEstrogen TherapyClinicalTrials.gov · fetched Nov 12, 2026
- Other progestogen therapyEstrogen TherapyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- PET/CT Imaging in Carriers of TTR MutationsNOT_YET_RECRUITING · started Nov 14, 2026ClinicalTrials.gov NCT07591038 · fetched Nov 12, 2026
- Open-Label, Multi-Stage Study to Optimize the Intraputaminal Administration of AB-1005 Using a Prescriptive Infusion Algorithm (PIA)PHASE2 · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07215403 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or RectumPHASE2 · RECRUITING · started Sep 11, 2026ClinicalTrials.gov NCT07811193 · fetched Nov 12, 2026
- A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial FibrillationPHASE2 · RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07625215 · fetched Nov 12, 2026
- An Observational Study to Learn How Mirena and Other Progestogen Treatments Are Used for Endometrial Protection in Women 40+ With a Uterus in the United States Receiving Estrogen Therapy, and Their Respective Health OutcomesACTIVE_NOT_RECRUITING · started Aug 31, 2026ClinicalTrials.gov NCT07795606 · fetched Nov 12, 2026
- A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)PHASE3 · RECRUITING · started Aug 3, 2026ClinicalTrials.gov NCT07723248 · fetched Nov 12, 2026
- An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia ARECRUITING · started Jul 16, 2026ClinicalTrials.gov NCT07088458 · fetched Nov 12, 2026
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic DysfunctionPHASE3 · RECRUITING · started Jun 1, 2026ClinicalTrials.gov NCT07192952 · fetched Nov 12, 2026
- A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)PHASE1 · RECRUITING · started Dec 3, 2025ClinicalTrials.gov NCT07244341 · fetched Nov 12, 2026
- A Study to Learn About How Well BAY 3401016 Works in Adults With Alport SyndromePHASE2 · ACTIVE_NOT_RECRUITING · started Nov 19, 2025ClinicalTrials.gov NCT07211685 · fetched Nov 12, 2026
- A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePHASE3 · RECRUITING · started Jun 17, 2025ClinicalTrials.gov NCT06944522 · fetched Nov 12, 2026
- A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid TumorsPHASE1_PHASE2 · RECRUITING · started Mar 21, 2025ClinicalTrials.gov NCT06914128 · fetched Nov 12, 2026
- A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced CoagulopathyPHASE1 · RECRUITING · started Mar 12, 2025ClinicalTrials.gov NCT06854640 · fetched Nov 12, 2026
- A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver CancerPHASE1 · RECRUITING · started Feb 28, 2025ClinicalTrials.gov NCT06764316 · fetched Nov 12, 2026
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)PHASE2 · RECRUITING · started Feb 13, 2025ClinicalTrials.gov NCT06760819 · fetched Nov 12, 2026
- Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Oct 22, 2024ClinicalTrials.gov NCT06631521 · fetched Nov 12, 2026
- A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)PHASE3 · RECRUITING · started Aug 28, 2024ClinicalTrials.gov NCT06452277 · fetched Nov 12, 2026
- A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 11, 2024ClinicalTrials.gov NCT06285643 · fetched Nov 12, 2026
- An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world ConditionsRECRUITING · started May 15, 2024ClinicalTrials.gov NCT06278207 · fetched Nov 12, 2026
- Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid CancerPHASE2 · RECRUITING · started Feb 14, 2024ClinicalTrials.gov NCT05783323 · fetched Nov 12, 2026
- First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)PHASE1_PHASE2 · RECRUITING · started Oct 25, 2021ClinicalTrials.gov NCT05099172 · fetched Nov 12, 2026
- Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate CancerRECRUITING · started Apr 16, 2021ClinicalTrials.gov NCT04489719 · fetched Nov 12, 2026
- Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by BayerPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 20, 2020ClinicalTrials.gov NCT04464226 · fetched Nov 12, 2026
- Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the BodyACTIVE_NOT_RECRUITING · started Apr 3, 2020ClinicalTrials.gov NCT04142437 · fetched Nov 12, 2026
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaPHASE2_PHASE3 · RECRUITING · started Jul 30, 2019ClinicalTrials.gov NCT03970447 · fetched Nov 12, 2026